Recent Price Movement and Market Performance
Jubilant Ingrevia’s shares have been under pressure over the past week, declining by 5.05%, significantly underperforming the Sensex benchmark, which fell by only 1.74% in the same period. The stock’s one-month performance is also weak, down 6.47%, while the broader market has gained 0.91%. Year-to-date, the stock has dropped sharply by 15.69%, compared to a more modest 3.46% decline in the Sensex. Over the last year, the stock has lost 12.71%, contrasting with the Sensex’s robust 10.29% gain. Even over three years, Jubilant Ingrevia’s 31.59% return trails the Sensex’s 38.36% rise.
Despite opening the day with a 2% gain and touching an intraday high of ₹614.7, the stock ultimately closed lower, reflecting selling pressure. The weighted average price indicates that more volume was traded near the day’s low, suggesting that sellers dominated the session. Additionally, the stock is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—signalling a bearish technical outlook. Notably, investor participation has increased, with delivery volume rising by 17.32% on 24 Feb compared to the five-day average, indicating heightened trading activity amid the decline.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Fundamental Strengths Amidst Weakness
On the positive side, Jubilant Ingrevia demonstrates a strong capacity to service its debt, with a low Debt to EBITDA ratio of 1.20 times, which is a reassuring metric for creditors and investors alike. The company’s return on capital employed (ROCE) stands at a respectable 10.6%, and it maintains an attractive valuation with an enterprise value to capital employed ratio of 2.7. This valuation is discounted relative to its peers’ historical averages, suggesting potential value for long-term investors.
Moreover, despite the stock’s negative returns over the past year, the company’s profits have risen by 33.2%, indicating operational improvements. The PEG ratio of 1 further suggests that the stock’s price is aligned with its earnings growth, which could appeal to value-oriented investors. Institutional investors hold a significant 30.17% stake in the company, and their holdings have increased by 1.15% over the previous quarter, signalling confidence from sophisticated market participants.
Challenges Weighing on the Stock
However, the company faces notable headwinds that have contributed to the stock’s recent decline. Over the past five years, Jubilant Ingrevia’s net sales have contracted at an annual rate of 0.45%, while operating profit has declined more sharply at 13.67% per annum. This poor long-term growth trajectory raises concerns about the company’s ability to sustain earnings momentum.
Quarterly financials reveal further weakness, with profit before tax excluding other income falling by 21.1% to ₹69.03 crores compared to the previous four-quarter average. Similarly, net profit after tax declined by 21.9% to ₹56.25 crores in the latest quarter. The company’s debtors turnover ratio, a measure of how efficiently it collects receivables, is low at 5.56 times for the half-year period, indicating potential inefficiencies in working capital management.
These fundamental challenges are reflected in the stock’s underperformance relative to broader market indices and sector peers. Jubilant Ingrevia has lagged the BSE500 index over the last three years, one year, and three months, underscoring its below-par performance in both the near and long term.
Is Jubilant Ingrev. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Conclusion: Why the Stock Is Falling
Jubilant Ingrevia’s recent share price decline is primarily driven by disappointing financial results and weak growth prospects. Despite some positive indicators such as rising profits and strong institutional interest, the company’s deteriorating sales, shrinking operating profits, and declining quarterly earnings have weighed heavily on investor sentiment. The stock’s technical position below all major moving averages and increased selling volume further exacerbate the downward pressure.
While the company’s valuation metrics and debt servicing ability offer some comfort, these factors have not been sufficient to offset concerns about its long-term growth and operational efficiency. Consequently, Jubilant Ingrevia’s shares have underperformed both the broader market and its sector peers, leading to the current downtrend in its stock price.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →